In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Scientists in China have identified specific physical behaviours that could provide early warning signs for Parkinson's ...

Bayer’s BAYRY wholly owned subsidiary, BlueRock Therapeutics, announced that the first patient in the phase I/IIa CLARICO study has received OpCT-001, an investigational iPSC-derived cell therapy, ...

Video. A unique programme in Rio de Janeiro is helping people with Parkinson’s disease manage their symptoms through the art of capoeira.

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...